Patents by Inventor Fiona Simpson

Fiona Simpson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240272164
    Abstract: Disclosed are methods for classifying tumors according to their responsiveness to a therapeutic agent based on the clustering status of a cell surface receptor element to which the therapeutic agent is capable of binding. Also disclosed are 5 methods for stratifying subjects with cancer into treatment subgroups based on this classification as well as methods for treating subjects so stratified.
    Type: Application
    Filed: January 16, 2024
    Publication date: August 15, 2024
    Inventors: Fiona SIMPSON, Shannon Rose LEFTWICH
  • Patent number: 10253107
    Abstract: The present invention relates to the use of endocytosis inhibitors, including clathrin-dependent endocytosis inhibitors such as inhibitors of dynamin and antibodies, for enhancing the immune response to cancer, and thereby treating cancers including cancer associated receptor positive cancers.
    Type: Grant
    Filed: October 28, 2013
    Date of Patent: April 9, 2019
    Assignee: THE UNIVERSITY OF QUEENSLAND
    Inventors: Fiona Simpson, Nicholas Andrew Saunders
  • Publication number: 20190041389
    Abstract: Disclosed are methods for classifying tumors according to their responsiveness to a therapeutic agent based on the clustering status of a cell surface receptor element to which the therapeutic agent is capable of binding. Also disclosed are5 methods for stratifying subjects with cancer into treatment subgroups based on this classification as well as methods for treating subjects so stratified.
    Type: Application
    Filed: February 12, 2016
    Publication date: February 7, 2019
    Inventors: Fiona SIMPSON, Shannon Rose LEFTWICH
  • Publication number: 20150293105
    Abstract: Disclosed are methods for classifying tumors into EGFR antagonist sensitive or resistant subtypes. Additionally, the present invention discloses methods for stratifying subjects with cancer into treatment subgroups based on whether their tumors fall into one of these subtypes and to methods for treating subjects so stratified.
    Type: Application
    Filed: October 28, 2013
    Publication date: October 15, 2015
    Applicant: THE UNIVERSITY OF QUEENSLAND
    Inventors: Fiona Simpson, Nicholas Andrew Saunders
  • Publication number: 20150284469
    Abstract: The present invention relates to the use of endocytosis inhibitors, including clathrin-dependent endocytosis inhibitors such as inhibitors of dynamin and antibodies, for enhancing the immune response to cancer, and thereby treating cancers including cancer associated receptor positive cancers.
    Type: Application
    Filed: October 28, 2013
    Publication date: October 8, 2015
    Inventors: Fiona Simpson, Nicholas Andrew Saunders